Efavirenz-Emtricitabine-Tenofovir

What is Efavirenz-Emtricitabine-Tenofovir?

Efavirenz-Emtricitabine-Tenofovir is a fixed-dose combination antiretroviral medication used in the treatment of HIV-1 infection. It combines three medications from two different drug classes into a single daily tablet, simplifying long-term HIV treatment.

Each component belongs to a different class and works in a distinct way:

• Efavirenz – a non-nucleoside reverse transcriptase inhibitor (NNRTI)
• Emtricitabine – a nucleoside reverse transcriptase inhibitor (NRTI)
• Tenofovir disoproxil fumarate – a nucleotide reverse transcriptase inhibitor, also grouped with the NRTI class

Approved and Common Uses

This combination is prescribed as a complete antiretroviral regimen for the treatment of HIV-1 infection in adults and certain adolescents. Because it contains three active medications that work through complementary mechanisms, it can be used as a stand-alone once-daily regimen, rather than requiring additional antiretroviral tablets.

Available Formulations and Strengths

This medication is available as:

• Oral fixed-dose combination tablets, containing set amounts of efavirenz, emtricitabine, and tenofovir disoproxil fumarate

It is intended to be taken as a single tablet once daily and is not typically available in other formulations.

What is the Recommended Dosage of Efavirenz-Emtricitabine-Tenofovir?

Dosage of this combination depends on several individual factors, including:

• Age – this combination is generally intended for adults and select adolescents who meet specific weight requirements
• Body weight, particularly when determining eligibility for adolescent use
• Kidney function – tenofovir is processed by the kidneys, so this medication requires adequate kidney function, and dose adjustments or alternative regimens may be needed if kidney function is reduced
• Liver function – efavirenz is processed by the liver, so liver impairment may affect suitability or require closer monitoring
• Other medications being taken, since interactions may affect how this regimen is dosed or whether it is appropriate at all

Because this is a fixed-dose combination intended for once-daily use as a complete regimen, this guide does not provide specific dosing amounts. Dosing and appropriateness must always be determined and supervised by a physician or HIV specialist.

This medication is often taken at bedtime, particularly when starting treatment, to reduce the impact of certain nervous system side effects associated with the efavirenz component. Patients should take it exactly as prescribed and should not skip or stop doses without consulting their treating specialist, as inconsistent dosing increases the risk of drug resistance.

How Efavirenz-Emtricitabine-Tenofovir Works

This combination works by blocking HIV replication at more than one step, using two complementary mechanisms:

• Efavirenz blocks an enzyme called reverse transcriptase directly, preventing the virus from converting its RNA into DNA.
• Emtricitabine and tenofovir are incorporated into the virus’s genetic material during replication, acting as faulty building blocks that stop the virus from completing this process (a mechanism sometimes described as chain termination).

By combining an NNRTI with two NRTI-class medications, this regimen attacks the virus through multiple points in its replication cycle, which helps reduce viral load, supports immune system recovery, and lowers the likelihood that the virus will develop resistance compared with using a single mechanism alone.

This medication does not cure HIV infection. It manages the virus by controlling replication and must be taken consistently, exactly as prescribed, for as long as a treating specialist recommends. Stopping treatment allows the virus to become active again and increases the risk of developing drug resistance.

Is a Prescription Required to Buy Efavirenz-Emtricitabine-Tenofovir Online?

Yes. This medication is available by prescription only.

Because HIV treatment requires an individualized regimen and ongoing monitoring, patients should:

• Be diagnosed and evaluated by a qualified healthcare provider, typically an infectious disease specialist or physician experienced in HIV care
• Undergo baseline and periodic laboratory testing, including viral load, CD4 count, and kidney function monitoring
• Receive regular follow-up to assess treatment effectiveness, side effects, and potential drug interactions

Important safety warnings:

• Avoid purchasing this medication from unlicensed or unverified online sources. Counterfeit antiretroviral medications are a recognized global health concern and can lead to treatment failure and drug resistance.
• Only obtain this medication from a licensed pharmacy with a valid prescription from a qualified specialist.

Side Effects of Efavirenz-Emtricitabine-Tenofovir

Common Side Effects

• Dizziness
• Vivid or unusual dreams
• Drowsiness or difficulty sleeping
• Trouble concentrating
• Headache
• Nausea, diarrhea, or upset stomach
• Fatigue
• Mild skin rash

Nervous system-related side effects (such as dizziness and unusual dreams), which are associated with the efavirenz component, often improve after the first few weeks of treatment and may be less noticeable when the dose is taken at bedtime.

Serious Side Effects

• Signs of severe skin reactions, including widespread rash, blistering, or peeling skin
• Signs of liver injury, such as yellowing of the skin or eyes (jaundice), dark urine, or severe fatigue
• Signs of kidney problems, such as decreased urination, swelling, or unusual tiredness
• New or worsening depression, anxiety, unusual thoughts, or changes in mood or behavior
• Signs of a rare but serious condition called lactic acidosis, including unusual muscle pain, difficulty breathing, stomach pain with nausea or vomiting, or feeling unusually cold
• Bone density changes with long-term use
• Signs of a severe allergic reaction, including swelling of the face or throat or difficulty breathing

Seek immediate medical attention if signs of a severe skin reaction, liver or kidney problems, lactic acidosis, severe allergic reaction, or significant mood or behavioral changes occur. Any new or worsening psychiatric symptoms should be reported to a healthcare provider promptly.

This list is not exhaustive. Patients should discuss their individual side effect risk with their treating physician.

Drug Interactions

This combination, particularly its efavirenz and tenofovir components, is associated with a range of drug interactions. Categories of concern include:

• Other HIV medications, particularly certain protease inhibitors, which may require dose adjustments or should not be combined with this regimen
• Other medications processed by the kidneys, since combining them with tenofovir may increase the risk of kidney-related side effects
• Hormonal contraceptives – the efavirenz component can reduce their effectiveness, so alternative or additional contraceptive methods are often recommended
• Certain seizure medications
• Certain cholesterol-lowering medications (statins), which may require dose adjustment
• Some sedatives and anti-anxiety medications, due to increased risk of excessive sedation
• Tuberculosis medications, such as rifampin, which can affect efavirenz levels
• Other medications containing tenofovir or similar agents, which should not be combined due to overlapping toxicity

Over-the-counter medications and supplements:

• Alcohol may intensify nervous system side effects such as dizziness or drowsiness and should be used cautiously
• Herbal supplements, particularly St. John’s Wort, should be avoided, as it significantly reduces efavirenz levels and can lead to treatment failure
• Nonsteroidal anti-inflammatory drugs (NSAIDs) used frequently or at high doses may increase the risk of kidney-related side effects when combined with tenofovir
• Any new over-the-counter medication or supplement should be reviewed with a healthcare provider or pharmacist before use

Patients should provide their prescribing specialist with a complete list of all medications, supplements, and herbal products, as this combination’s interaction profile is extensive.

Safety & Important Considerations

• Kidney disease: This medication requires adequate kidney function due to the tenofovir component. Kidney function should be assessed before starting treatment and monitored periodically throughout therapy.
• Liver disease: Efavirenz is processed by the liver, and this combination carries a risk of liver-related side effects. Patients with pre-existing liver disease require closer monitoring, and periodic liver function testing is generally recommended.
• Pregnancy and breastfeeding: Treatment decisions during pregnancy require careful specialist evaluation, weighing the benefits of HIV management against potential risks. Any decision regarding use during pregnancy or breastfeeding should be made in close consultation with an HIV specialist.
• Bone health: Long-term use of tenofovir-containing regimens has been associated with decreases in bone mineral density in some patients; bone health monitoring may be recommended for certain individuals.
• Mental health monitoring: Because efavirenz has been associated with mood changes, depression, and in rare cases more serious psychiatric symptoms, patients with a history of mental health conditions should discuss this risk with their specialist before starting treatment.
• Children and older adults: This combination is generally intended for adults and adolescents meeting specific weight criteria; it is not typically used in younger children. Older adults may have reduced kidney function, which should be assessed before starting treatment.
• Monitoring requirements: Regular viral load testing, CD4 count monitoring, kidney function tests, liver function tests, and periodic bone density assessment (when clinically indicated) are standard components of therapy.
• FDA and regulatory safety notices: This combination carries recognized warnings regarding psychiatric symptoms, kidney function changes, lactic acidosis, severe liver problems (including fatty liver with lactic acidosis), and bone density loss.

This medication should be used according to its approved indications as a complete HIV treatment regimen. Off-label use is not addressed in this guide.

Who This Medication Is For

This combination is generally prescribed for:

• Adults diagnosed with HIV-1 infection who are starting or continuing antiretroviral therapy
• Certain adolescents who meet specific age and weight requirements
• Patients whose treatment team has determined that an efavirenz-based, NNRTI-containing regimen is appropriate for their specific viral and health profile, including adequate kidney and liver function

Use is determined by an HIV specialist based on viral characteristics, prior treatment history, kidney and liver function, other health conditions, and current treatment guidelines.

Who Should Not Take Efavirenz-Emtricitabine-Tenofovir

This medication may not be appropriate for individuals who:

• Have a known hypersensitivity or allergy to efavirenz, emtricitabine, tenofovir, or related compounds
• Have significantly reduced kidney function, unless a specialist determines an appropriate monitoring plan
• Have severe liver impairment, unless carefully managed under specialist supervision
• Are taking certain medications known to have dangerous interactions with this combination (such as specific other antiretroviral, seizure, or kidney-affecting medications)
• Have a personal history of severe psychiatric illness that a specialist determines could be significantly worsened by the efavirenz component

Important precautions apply to individuals with a history of depression, anxiety, kidney disease, osteoporosis or low bone density, or those relying on hormonal contraception, who should discuss alternative or backup contraceptive methods with their provider.

This is not a complete list. A licensed HIV specialist must review each patient’s full medical and psychiatric history, kidney and liver function, and current medications before prescribing this combination.

What to Do If You Miss a Dose

• Take the missed dose as soon as you remember, unless it is close to the time of your next scheduled dose.
• Do not double up or take an extra dose to make up for a missed one.
• Because consistent, uninterrupted once-daily dosing is essential to maintaining viral suppression and preventing HIV drug resistance, contact your treating specialist promptly if you miss doses, especially if this occurs more than once.
• If you are unsure what to do, contact your licensed HIV specialist or pharmacist for guidance rather than guessing.

Alternatives to Efavirenz-Emtricitabine-Tenofovir

This product combines efavirenz, emtricitabine, and a tenofovir formulation. Related pages include Efavirenz and the appropriate tenofovir parent page. Confirm whether the product contains tenofovir disoproxil fumarate or tenofovir alafenamide before publishing ingredient-specific content.

Storage Instructions

• Store at room temperature, generally between 68°F and 77°F (20°C to 25°C), unless otherwise directed on the label.
• Keep in the original container, protected from excess moisture and light.
• Avoid storing in bathrooms or other high-humidity environments.
• Keep out of reach of children and pets; use a secure or child-resistant container if young children are present in the home.
• Do not use medication that is expired or shows unusual changes beyond normal variation.

Disclaimer

This page is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. The information provided here is not a substitute for professional medical guidance.

Patients must consult a licensed physician or infectious disease/HIV specialist before starting, changing, or stopping this medication. HIV treatment requires an individualized regimen, and all treatment decisions must be based on a full clinical evaluation, including laboratory testing and ongoing monitoring, by a qualified healthcare specialist.